type: position_score table: filename: ENCFF078TXM.tabix.bed.gz header_mode: none zero_based: true format: tabix chrom: column_index: 0 pos_begin: column_index: 1 pos_end: column_index: 2 scores: - id: TF_ChIP-seq_ENCSR325RLL column_index: 3 type: float desc: 'TF_ChIP-seq ENCSR325RLL [biosample_summary="Homo sapiens K562" and target="POLR2B"]' histogram: type: number number_of_bins: 100 meta: summary: 'TF_ChIP-seq ENCSR325RLL [biosample_summary="Homo sapiens K562" and target="POLR2B"]' description: "**status**: released\n\n**biological\\_replicates**: Rep 1, Rep 2\n\ \n**summary**: \n\n**output\\_type**: optimal IDR thresholded peaks\n\n**audit\\\ _internal\\_action**: File {ENCFF078TXM|/files/ENCFF078TXM/} with status 'released'\ \ is derived from file {ENCFF419RSJ|/files/ENCFF419RSJ/} with status 'archived'.\n\ \n**audit\\_internal\\_action**: Archived analysis {ENCAN411CII|/analyses/ENCAN411CII/}\ \ has in progress subobject quality standard {encode3-tf-chip|/quality-standards/encode3-tf-chip/}\n\ \n**audit\\_warning**: Processed alignments file {ENCFF995XZH|/files/ENCFF995XZH/}\ \ processed by ChIP-seq ENCODE3 GRCh38 pipeline has 19503600 usable fragments.\ \ The minimum ENCODE standard for each replicate in a ChIP-seq experiment targeting\ \ POLR2B-human and investigated as a transcription factor is 10 million usable\ \ fragments. The recommended value is > 20 million, but > 10 million is acceptable.\ \ (See {ENCODE ChIP-seq data standards|/data-standards/chip-seq/} )" labels: reference_genome: hg38/genomes/GRCh38-hg38 accession: ENCSR325RLL status: released assay_term_name: ChIP-seq simple_biosample_summary: '' biosample_summary: Homo sapiens K562 replication_type: isogenic biosample_ontology: /biosample-types/cell_line_EFO_0002067/ perturbed: false doi: 10.17989/ENCSR325RLL date_created: '2015-06-30T21:54:02.787057+00:00' date_released: '2018-01-26' submitter_comment: We note that this ChIP-seq experiment was performed using an antibody for which we have provided a compliant primary characterization but no secondary characterization. A secondary characterization using IP-MS was attempted, but the experiment failed. There is no remaining antibody from this lot number and therefore additional secondary characterizations cannot be attempted. However, because the replicate ChIP-seq datasets passed the ENCODE IDR ChIP-seq data quality standards, we are releasing the data to the public. target: POLR2B